Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(2 sites)

United States

MedStar Washington Hospital Center, Washington D.C., District of Columbia

University of South Florida Health South Tampa Center for Advanced Healthcare, Tampa, Florida